Journal of Dali University ›› 2025, Vol. 10 ›› Issue (8): 51-56.DOI: 10. 3969 / j. issn. 2096-2266. 2025. 08. 007

Previous Articles     Next Articles

The Function of FIBCD1 in Proliferation of Human Lung Cancer Cell Line A549

Li Hua, Zhang Min, Fang Peifei, Zhang Yanfei   

  1. (School of Medical Science, Anhui Institute of Medicine, Hefei 230601, China)
  • Received:2024-12-26 Revised:2025-01-08 Online:2025-08-15 Published:2025-09-06

Abstract: Objective: To explore the role of fibrinogen-related C domain 1 (FIBCD1) in lung cancer. Methods: A FIBCD1-
knockdown A549 lung cancer cell line was constructed using lentivirus-mediated RNA interference. The knockdown efficiency was
validated by quantitative real-time PCR and Western blotting. Cell proliferation was assessed by MTT assay, while cell cycle
distribution and apoptosis were analyzed via flow cytometry. The effects of FIBCD1 knockdown on colony formation and tumor growth
were evaluated using colony formation assay and in vivo xenograft tumor formation assay in nude mice. Results: FIBCD1 knockdown
significantly inhibited A549 cell proliferation, induced G0/G1 phase cell cycle arrest, and markedly increased the apoptotic rate.
Colony formation assay further confirmed that FIBCD1 suppression impaired the colony-forming ability of A549 cells. In vivo
experiments showed that FIBCD1 knockdown significantly attenuated tumor growth in nude mice, with reduced tumor weight and in
vivo luminescence intensity compared to the control group. Conclusion: FIBCD1 exerts a role in promoting proliferation and inhibiting
apoptosis in lung cancer cells. Its high expression may be closely associated with tumor growth. Suppression of FIBCD1 significantly
reduces the tumorigenic potential of lung cancer cells, indicating that FIBCD1 holds promise as a potential therapeutic target for lung
cancer.

Key words: fibrinogen-related C domain 1, flow cytometry, colony formation, in vivo xenograft tumor formation assay

CLC Number: